蓝帆医疗：子公司Lithonic?冠脉血管内冲击波治疗系统获得CE证书

Core Viewpoint - The company Bluepha Medical (002382.SZ) announced that its subsidiary, Biosensors Interventional Technologies Pte. Ltd., has received CE certification for its Lithonic coronary intravascular shockwave treatment system, which is designed to treat severely calcified narrow areas in blood vessels [1] Group 1 - The Lithonic system is intended for use in areas where balloon dilation or stent expansion is insufficient due to calcification [1] - The system operates by releasing high-pressure shockwaves to pre-treat calcified lesions, utilizing an electrolytic effect generated by electrodes in an electrolyte solution [1] - This innovative approach aims to reduce the risk of complications such as vascular perforation and no-reflow associated with traditional calcification treatment methods [1]